Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in chemo-insensitive sarcomas
NCT00401388Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Nov 2006
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of perifosine in chondrosarcoma, alveolar soft part sarcoma (ASPS), extraskeletal myxoid chondrosarcoma (EMC), sponsored by COSCIENS Biopharma Inc.. Started Nov 2006; status: completed.
02
Drugs
perifosine
03
Conditions
chondrosarcomaalveolar soft part sarcoma (ASPS)extraskeletal myxoid chondrosarcoma (EMC)
Beyond the preview
Go deeper on NCT00401388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401388.